Duracrin

New Haven, United States

Duracrin is a biotechnology company developing technologies or products in the life sciences sector.

$1.0M raised

Feb 2026

Seed

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Duracrin

How much funding has Duracrin raised?

Duracrin has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in February 2026.

Where is Duracrin headquartered?

Duracrin is headquartered in New Haven, United States.

What does Duracrin do?

Duracrin is a biotechnology company developing technologies or products in the life sciences sector.

What stage is Duracrin at?

Duracrin is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 16, 2026.

MLA

"Duracrin — Funding & Investors." VCBacked, February 16, 2026, https://www.vcbacked.co/company/duracrin. Accessed July 2, 2026.

APA

VCBacked. (2026). Duracrin — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/duracrin

Wikipedia (cite web)

{{cite web |title=Duracrin — Funding & Investors |url=https://www.vcbacked.co/company/duracrin |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 16, 2026.